you are here: HomeNewscoronavirus

COVID-19 update | Germany limits travel from French region over virus variant

Germany's disease control agency, the Robert Koch Institute, said it would add Moselle to the list of variant of concern areas that already includes countries such as the Czech Republic, Portugal and the United Kingdom.

February 28, 2021 / 06:34 PM IST
Representative Image

Representative Image

Germany announced Sunday that travelers from Frances northeastern Moselle region will face additional restrictions due to the high rate of variant coronavirus cases there.

Germany's disease control agency, the Robert Koch Institute, said it would add Moselle to the list of variant of concern areas that already includes countries such as the Czech Republic, Portugal and the United Kingdom.

Travelers from those areas must produce a recent negative coronavirus test before entering Germany.

COVID-19 Maharashtra Update: Night Curfew extended in Pune till March 14

The Moselle region in northeastern France includes the city of Metz and borders the German states of Saarland and Rhineland-Palatinate.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Clement Beaune, the French minister for European affairs, said France regrets the decision and is in negotiations with Germany to try to lighten the measures for 16,000 inhabitants of Moselle who work across the border. Specifically, he said France does not want them to face the daily PCR virus tests that Germany has applied elsewhere to travelers along some borders.

We dont want that, he said.

He said France is pushing for the use of easier, faster testing methods and for tests every 2-3 days rather than daily. More talks were expected later Sunday, he said.

The Robert Koch Institute recorded 7,890 newly confirmed cases of COVID-19 in Germany over the past day, taking the total to over 2.4 million cases. The death toll rose by 157 to 70,045.
Associated Press
first published: Feb 28, 2021 06:34 pm

stay updated

Get Daily News on your Browser
Sections